-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Disc Medicine, Raises Price Target to $86

Benzinga·09/16/2026 12:41:40
語音播報
Wells Fargo analyst Derek Archila maintains Disc Medicine (NASDAQ:IRON) with a Overweight and raises the price target from $79 to $86.